Cleared Traditional

K072822 - FUNHALER, MODEL V-201E

K072822 is an FDA 510(k) clearance for FUNHALER, manufactured by Infamed , Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K072822 · Infamed , Ltd. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
55d
Days
Class 2
Risk

K072822 is an FDA 510(k) clearance for the FUNHALER, MODEL V-201E. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Infamed , Ltd. (South West Ranches, US). The FDA issued a Cleared decision on November 26, 2007 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K072822

510(k) Number K072822 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2007
Decision Date November 26, 2007
Days to Decision 55 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 140d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 441
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K072822.
AG-CLASSIC
K072494 · Medel S.P.A. · Feb 2008
AEROSOL SYSTEM
K063716 · Amici, Inc. · Dec 2007
MODIFICATION TO: EFLOW ELECTRONIC INHALER/NEBULIZER
K072670 · Pari Innovative Manufacturers, Inc. · Dec 2007
AKITA2 APIXNEB
K072019 · Activaero America, Inc. · Nov 2007
AMSURE NEBULIZER
K070411 · Amsino International, Inc. · Oct 2007
OPTICHAMBER ADVANTAGE ANTI-STATIC VALVED HOLDING CHAMBER
K072418 · Respironics New Jersey, Inc. · Sep 2007